Abstract
Both enveloped and non-enveloped viruses from different families may use heparan sulfates (HS) to bind to and / or enter into their host cells. The interactions between viruses and HS can be inhibited by a novel class of antiviral compounds, the N,N-bisheteryl derivatives of 3,12-diaza-6,9-diazoniadispiro(5,2,5,2) hexadecane which bind to specific structural moieties of HS. By this way these compounds block adsorption of viruses that use HS as their initial interaction site with the cell, e.g. herpes simplex viruses, cytomegalovirus, respiratory syncytial virus, and human immunodeficiency viruses.
Keywords: receptor, heparan sulfate, proteoglycans, dispirotripiperazine, virus, antiviral
Letters in Drug Design & Discovery
Title: Novel Opportunities to Study and Block Interactions between Viruses and Cell Surface Heparan Sulfates by using Dispirotripiperazines
Volume: 1 Issue: 4
Author(s): M. Schmidtke, P. Wutzler and V. Makarov
Affiliation:
Keywords: receptor, heparan sulfate, proteoglycans, dispirotripiperazine, virus, antiviral
Abstract: Both enveloped and non-enveloped viruses from different families may use heparan sulfates (HS) to bind to and / or enter into their host cells. The interactions between viruses and HS can be inhibited by a novel class of antiviral compounds, the N,N-bisheteryl derivatives of 3,12-diaza-6,9-diazoniadispiro(5,2,5,2) hexadecane which bind to specific structural moieties of HS. By this way these compounds block adsorption of viruses that use HS as their initial interaction site with the cell, e.g. herpes simplex viruses, cytomegalovirus, respiratory syncytial virus, and human immunodeficiency viruses.
Export Options
About this article
Cite this article as:
Schmidtke M., Wutzler P. and Makarov V., Novel Opportunities to Study and Block Interactions between Viruses and Cell Surface Heparan Sulfates by using Dispirotripiperazines, Letters in Drug Design & Discovery 2004; 1 (4) . https://dx.doi.org/10.2174/1570180043398768
DOI https://dx.doi.org/10.2174/1570180043398768 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Targets in Respiratory Viral Infections
Current Medicinal Chemistry Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Natural Bioactives as Potential Therapeutic Modalities Against NeuroAIDS
Current Topics in Medicinal Chemistry The Role of Vasopressin in Affective Disorders: Possible Targets of Intervention
Central Nervous System Agents in Medicinal Chemistry CCR1 and CCR2 Antagonists
Current Topics in Medicinal Chemistry HIV-1 Tat Protein Exposure Potentiates Ethanol Reward and Reinstates Extinguished Ethanol-Conditioned Place Preference
Current HIV Research HIV-1-Associated Dementia During HAART Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Combining Drug and Immune Therapy: A Potential Solution to Drug Resistance and Challenges of HIV Vaccines?
Current HIV Research Novel Genetic and Peptide-Based Strategies Targeting the Bcl-2 Family, an Update
Recent Patents on DNA & Gene Sequences Astrocytes: Adhesion Molecules and Immunomodulation
Current Drug Targets Echinocandins for the Nursery: An Update
Current Drug Metabolism A Pictorial Review of Intracranial Haemorrhage Revisited
Current Medical Imaging Applications of Animal Models of Infectious Arthritis in Drug Discovery:A focus on Alphaviral Disease
Current Drug Targets Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19
Current Neuropharmacology Nanoparticle- and Liposome-carried Drugs: New Strategies for Active Targeting and Drug Delivery Across Blood-brain Barrier
Current Drug Metabolism Using Biologic Agents in Pediatric Rheumatologic Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cognitive Consequences of a Sustained Monocyte Type 1 IFN Response in HIV-1 Infection
Current HIV Research Editorial [Hot Topic:Active and Passive Aβ-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part I (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]
CNS & Neurological Disorders - Drug Targets Neuro-Immune-Endocrine Mechanisms During Septic Shock: Role For Nitric Oxide in Vasopressin and Oxytocin Release
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects
Current Pharmaceutical Design